New brand and website for a biotech preparing to enter the clinic
Partnering with X4 Pharmaceuticals, Inc. in its first FDA approval in rare disease
Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Rebrand to usher in the next phase of the C4 Therapeutics story.
A Landmark for Genome Editing
A clinical-stage debut for a precision player in the neuro space
New company name and brand identity support a vision fueled by optimism
